Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.4B | 4.5B | 4.4B | 4.2B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.5B | 2.6B | 2.5B | 2.4B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 80M | 77M | 87M | 83M |
Other income expense | 129M | 127M | 131M | 129M |
Pretax income | 687M | 1.4B | 645M | 1.1B |
Tax provision | 104M | 281M | 134M | 222M |
Net income | 583M | 1.1B | 511M | 829M |
Basic EPS | 5.9 | 10.8 | 5.1 | 8.2 |
Diluted EPS | 5.8 | 10.6 | 5 | 8.0 |
Basic average shares | 98.5M | 99.2M | 100.4M | 101.6M |
Diluted average shares | 100M | 101.2M | 102.2M | 103.4M |
EBITDA | — | — | — | — |
Net income from continuing op. | 583M | 1.1B | 511M | 829M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |